Skip to main content

Table 3 Multivariate analysis of clinical features and ERβ1 expression with recurrence

From: Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

Feature (reference)

HR [CI 95%]

p value

ERβ1 > 40% (vs. ERβ1 < 40%)

1.51 [0.76–3.01]

0.283

Agea

1.02 [1.02–1.05]

0.114

Stage IIA

3.23 [1.16–8.94]

0.024*

Stage IIB

3.34 [1.08–10.39]

0.036*

Stage III/IV

6.40 [2.11–19.39]

0.00102*

Chemotherapy Yes (vs. no)

0.51 [0.24–1.09]

0.0816

  1. Footnote: aContinuous (years). * P<0.05
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us